All Stories

  1. One health intervention for the control and elimination of scrub typhus, anthrax, and brucellosis in Southeast Asia: a systematic review
  2. One Health intervention for elimination of anthrax in an endemic district of Odisha: A baseline and endline study
  3. Social and biological evaluation of antimicrobial resistance (SOBEAR) in rural India: a study protocol
  4. Diagnostic Validation and Feasibility of a Non-invasive Haemoglobin Screening Device (EzeCheck) for 'Anaemia Mukt Bharat' in India
  5. Base catalyzed one-pot thia-Michael addition-oxidation reaction of hetero-aromatic thiols to 2-aryl-3-nitro-2H-chromenes and their antibacterial evaluation
  6. Suspected human anthrax outbreak investigation in a tribal village of Koraput, India, 2021
  7. Investigation of human anthrax outbreak in Koraput district of Odisha, India
  8. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey
  9. Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India
  10. Non-communicable disease multimorbidity among tribal older adults in India: evidence from Study on Global AGEing and adult health, 2015
  11. Odisha tribal family health survey: methods, tools, and protocols for a comprehensive health assessment survey
  12. Gender differences in COVID-19 knowledge, risk perception, and public stigma among the general community: Findings from a nationwide cross-sectional study in India
  13. Gender dimensions of health-related challenges among urban poor during COVID-19 pandemic in low-and middle-income countries: a systematic review and gap analysis
  14. COVID-19 vaccine hesitancy among school children aged 12-14 years: A cross-sectional study from Bhubaneswar, Odisha, India
  15. Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India
  16. Identification of potential inhibitor against CTX-M-3 and CTX-M-15 proteins: an in silico and in vitro study
  17. Hepatitis B virus infection among the tribal and particularly vulnerable tribal population from an eastern state of India: Findings from the serosurvey in seven tribal dominated districts, 2021–2022
  18. Perception and determinants leading to antimicrobial (mis)use: A knowledge, attitude, and practices study in the rural communities of Odisha, India
  19. Effectiveness of the BBV-152 and AZD1222 vaccines among adult patients hospitalized in tertiary hospitals in Odisha with symptomatic respiratory diseases: A test-negative case–control study
  20. Use of Portable Automated Auditory Brainstem Responses in Universal Neonatal Hearing Screening: A Mixed-Method Study in Odisha, India
  21. Access to Maternal and Child Health Services during the COVID-19 Pandemic: An Explorative Qualitative Study in Odisha, India
  22. Outbreaks and sporadic cases of japanese encephalitis in the state of Odisha, India: Outcome of 7 years of laboratory surveillance
  23. Community engagement and involvement in managing the COVID-19 pandemic among urban poor in low-and middle-income countries: a systematic scoping review and stakeholders mapping
  24. Seroprevalence of human brucellosis among the tribal and non-tribal population residing in an eastern state of India: Findings from the state-wide serosurvey
  25. Factors associated with COVID-19 stigma during the onset of the global pandemic in India: A cross-sectional study
  26. Housing-related challenges during COVID-19 pandemic among urban poor in low- and middle-income countries: A systematic review and gap analysis
  27. A Systematic Review of Water, Sanitation, and Hygiene for Urban Poor in Low- and Middle-Income Countries during the COVID-19 Pandemic through a Gendered Lens
  28. Analysis of the COVID-19 testing parameters and progression of the pandemic at the district level: findings from the ICMR Hundred Million Test (HMT) database during the first wave in India
  29. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance
  30. Scrub typhus seroprevalence from an eastern state of India: findings from the state-wide serosurvey
  31. Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A prospective, longitudinal cohort study
  32. Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study
  33. Effective interventions to ensure MCH (Maternal and Child Health) services during pandemic related health emergencies (Zika, Ebola, and COVID-19): A systematic review
  34. Antibacterial and genotoxic activity of Bixa orellana, a folk medicine and food supplement against multidrug resistant clinical isolates
  35. Impact of smokeless cooking fuel use on health status of women in a rural setting of eastern India
  36. Assessment of socio-behavioural correlates and risk perceptions regarding anthrax disease in tribal communities of Odisha, Eastern India
  37. Resolution of Resilience: Empirical Findings on the Challenges Faced and the Mitigation Strategies Adopted by Community Health Workers (CHWs) to Provide Maternal and Child Health (MCH) Services during the COVID-19 Pandemic in the Context of Odisha, India
  38. Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India
  39. Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
  40. Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India
  41. Anti-SARS-CoV-2 antibodies among vaccinated healthcare workers: Repeated cross-sectional study
  42. Development & validation of scales to assess stigma related to COVID-19 in India
  43. Effectiveness of introduction of JEV vaccination into routine immunization program in a tribal district of Odisha
  44. Discovery of phyto-compounds as novel inhibitors against NDM-1 and VIM-1 protein through virtual screening and molecular modelling
  45. Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines
  46. Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al.
  47. Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection
  48. COVID-19 in children in Odisha state, India: a retrospective review
  49. Breakthrough SARS‐CoV‐2 infections among BBV‐152 (COVAXIN®) and AZD1222 (COVISHIELD TM ) recipients: Report from the eastern state of India
  50. A systematic review and meta-analysis of screening and diagnostic accuracy for hearing loss among under-five children in South-Asian region
  51. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
  52. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
  53. Pooled testing for SARS‐CoV‐2 infection in an automated high‐throughput platform
  54. Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies
  55. One Health approach for elimination of human anthrax in a tribal district of Odisha: Study protocol
  56. Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
  57. Prevalence and molecular characterization of β-lactamase producers and fluoroquinolone resistant clinical isolates from North East India
  58. Seroprevalence of IgG antibody against SARS-CoV-2 among health care workers of anaesthesia departments from various hospital settings in India
  59. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2
  60. A qualitative exploratory study using One Health approach for developing an intervention package for elimination of human anthrax in an endemic district of Odisha, India
  61. Health system preparedness & community participation in Japanese encephalitis/acute encephalitis syndrome (JE/AES) prevention in a tribal district of Odisha, India
  62. Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys
  63. Saliva for diagnosis of SARS‐CoV‐2: First report from India
  64. Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity
  65. SARS-CoV-2 IgG antibody responses in rt-PCR positive cases: first report from India
  66. Stakeholders’ Perspective for Improved Universal Newborn Hearing Screening Uptake in Odisha, India
  67. Saliva as a potential clinical specimen for diagnosis of SARS-CoV-2
  68. The Landscape of Anthrax Prevention and Control: Stakeholders’ Perceptive in Odisha, India
  69. Etiology of Non-Rotaviral Diarrhea in Hospitalized Children Under Five Years of Age
  70. Mapping of Health Technology Assessment (HTA) teaching and training initiatives: Landscape for evidence-based policy decisions in India
  71. Epidemiology of viral disease outbreaks in Odisha, India (2010–2019)
  72. Feasibility of Pooled Testing in a Fully Automated High Throughput Platform for Effective Management of SARS-CoV-2 in India
  73. Etiology of childhood diarrhoea among under five children and molecular analysis of antibiotic resistance in isolated enteric bacterial pathogens from a tertiary care hospital, Eastern Odisha, India
  74. Role of Natural Product in Modulation of Drug Transporters and New Delhi Metallo-β Lactamases
  75. Letters to the Editor
  76. A cross-sectional study on aetiology of diarrhoeal disease, India
  77. Green and ecofriendly synthesis of silver nanoparticles: Characterization, biocompatibility studies and gel formulation for treatment of infections in burns
  78. Vibrio cholerae O1 El Tor variant and emergence of Haitian ctxB variant in the strains isolated from South India
  79. Isolation of NDM-1-producing multidrug-resistant Pseudomonas putida from a paediatric case of acute gastroenteritis, India
  80. Transition Densities and Sample Frequency Spectra of Diffusion Processes with Selection and Variable Population Size
  81. Emergence of influenza A (H1N1) PDM09 in the remote Islands of India - A molecular approach
  82. Shewanella algae in acute gastroenteritis
  83. Multidrug-Resistant <i>Vibrio cholerae</i> O1 was Responsible for a Cholera Outbreak in 2013 in Bagalkot, North Karnataka
  84. Occult hepatitis B infection among individuals belonging to the aboriginal Nicobarese tribe of India
  85. Changing patterns and widening of antibiotic resistance inShigellaspp. over a decade (2000–2011), Andaman Islands, India
  86. Prevalence of Mutations in Basal Core Promoter and Precore Region of Hepatitis B Virus in Vaccinated and Nonvaccinated Individuals of the Aboriginal Nicobarese Tribe of Car Nicobar Island, India
  87. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) Producing and Multidrug Resistant Uropathogens Causing Urinary Tract Infections in Andaman Islands, India
  88. Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011
  89. Emergence of an Unusual Genotype of Rotavirus in Andaman and Nicobar Islands, India
  90. Emergence of Multidrug-Resistant Vibrio cholerae O1 Biotype El Tor in Port Blair, India
  91. High-risk HPV infection among the tribal and non-tribal women of the Andaman and Nicobar Islands, India
  92. Dengue: a newly emerging viral infection in Andaman and Nicobar Islands, India
  93. Isolation and molecular characterization of Chikungunya virus from the Andaman and Nicobar archipelago, India: evidence of an East, Central, and South African genotype
  94. H1N1 influenza A outbreak among the Nicobarese, an aboriginal tribe of the Andaman and Nicobar Islands, India
  95. Third-generation cephalosporin resistance in clinical isolate of Shigella sonnei in Andaman & Nicobar Islands, India
  96. Prevalence of the plasmid-mediated quinolone resistance determinants among clinical isolates of Shigella sp. in Andaman & Nicobar Islands, India
  97. Rapid Emergence of Third-Generation Cephalosporin Resistance in Shigella Sp. Isolated in Andaman and Nicobar Islands, India
  98. Acute Diarrhea in Children after 2004 Tsunami, Andaman Islands